NYSE:MED Medifast (MED) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free MED Stock Alerts $24.41 -0.59 (-2.36%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$23.78▼$24.9950-Day Range$24.41▼$38.3252-Week Range$23.78▼$109.52Volume457,983 shsAverage Volume512,387 shsMarket Capitalization$267.05 millionP/E Ratio3.94Dividend YieldN/APrice Target$53.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Medifast alerts: Email Address Medifast MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside119.2% Upside$53.50 Price TargetShort InterestBearish29.30% of Float Sold ShortDividend StrengthN/ASustainability-4.07Upright™ Environmental ScoreNews Sentiment0.41Based on 8 Articles This WeekInsider TradingSelling Shares$159,850 Sold Last QuarterProj. Earnings Growth115.79%From $0.95 to $2.05 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.22 out of 5 starsConsumer Staples Sector31st out of 134 stocksMiscellaneous Food Preparations & Kindred Products Industry1st out of 4 stocks 3.0 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days.Read more about Medifast's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted29.30% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 7.Change versus previous monthShort interest in Medifast has recently increased by 4.35%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast has only been increasing its dividend for 1 years. Previous Next 1.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a -4.19% net impact score from Upright. The largest negative impact of Medifast in category "GHG emissions" seems to be driven mostly by its "Meal replacement soups", "Meal replacement bars", "Meal replacement drinks", and "Protein bars" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -4.07. Previous Next 3.0 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Medifast this week, compared to 4 articles on an average week.Search Interest24 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 140% compared to the previous 30 days.MarketBeat Follows9 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 125% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $159,850.00 in company stock.Percentage Held by InsidersOnly 2.50% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to grow by 115.79% in the coming year, from $0.95 to $2.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 3.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 3.94, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 16.22.Price to Book Value per Share RatioMedifast has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medifast's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Medifast Stock (NYSE:MED)Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More MED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesMay 20 at 3:02 PM | investorplace.comInvest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street WrongMay 20 at 8:14 AM | finance.yahoo.comMedifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss MedicationsMay 20 at 8:00 AM | businesswire.comMedifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss MedicationsMay 20 at 1:38 AM | americanbankingnews.comZacks Research Weighs in on Medifast, Inc.'s Q2 2024 Earnings (NYSE:MED)May 18 at 12:59 PM | sg.finance.yahoo.comMED Jun 2024 65.000 putMay 16, 2024 | bizjournals.comMedifast closes Maryland warehouse, lays off 62 workersMay 13, 2024 | investorplace.comPocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to RoarMay 9, 2024 | finance.yahoo.comQ1 2024 LifeMD Inc Earnings CallMay 6, 2024 | finance.yahoo.comEarnings To Watch: Nature's Sunshine (NATR) Reports Q1 Results TomorrowMay 1, 2024 | msn.comMedifast Just Hit Its 20th 5-Year Low. Are You Smart/Dumb Enough to Buy?May 1, 2024 | finance.yahoo.comMedifast, Inc. (NYSE:MED) Q1 2024 Earnings Call TranscriptMay 1, 2024 | ca.investing.comOlaplex Earnings: What To Look For From OLPXMay 1, 2024 | finance.yahoo.comMedifast First Quarter 2024 Earnings: EPS Misses ExpectationsApril 30, 2024 | za.investing.comMedifast stock plunges on earnings miss, weak outlookApril 30, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: The Chefs’ Warehouse (CHEF), Medifast (MED) and Marine Products (MPX)April 30, 2024 | finance.yahoo.comWhy Medifast (MED) Shares Are Trading Lower TodayApril 30, 2024 | investorplace.comWhy Is Medifast (MED) Stock Down 20% Today?April 30, 2024 | msn.comMedifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionApril 30, 2024 | finance.yahoo.comMedifast Inc (MED) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...April 30, 2024 | finance.yahoo.comQ1 2024 Medifast Inc Earnings CallApril 29, 2024 | investorplace.comMED Stock Earnings: Medifast Misses EPS, Beats Revenue for Q1 2024April 29, 2024 | marketwatch.comMedifast Shares Fall Below 52-Week Low Post-Market Following 1Q ResultsApril 29, 2024 | finance.yahoo.comMedifast Announces First Quarter 2024 Financial ResultsApril 29, 2024 | finance.yahoo.comMedifast's (NYSE:MED) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 14.3%April 29, 2024 | finance.yahoo.comMedifast Inc (MED) Q1 2024 Earnings: Revenue Declines Amid Market ChallengesSee More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2024Today5/20/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees634Year FoundedN/APrice Target and Rating Average Stock Price Target$53.50 High Stock Price Target$82.00 Low Stock Price Target$25.00 Potential Upside/Downside+119.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$6.20 Trailing P/E Ratio3.94 Forward P/E Ratio25.69 P/E GrowthN/ANet Income$99.42 million Net Margins7.55% Pretax Margin9.70% Return on Equity36.64% Return on Assets23.16% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio2.25 Sales & Book Value Annual Sales$1.07 billion Price / Sales0.25 Cash Flow$10.61 per share Price / Cash Flow2.30 Book Value$18.50 per share Price / Book1.32Miscellaneous Outstanding Shares10,940,000Free Float10,664,000Market Cap$267.05 million OptionableOptionable Beta1.19 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Daniel R. Chard (Age 59)Executive Chairman & CEO Comp: $1.94MMr. James P. Maloney CPA (Age 56)Chief Financial Officer Comp: $823.91kMr. Anthony E. Tyree (Age 59)Chief Business Operations Officer Comp: $655.86kMr. Jason L. Groves Esq. (Age 53)Executive VP, General Counsel & Corporate Secretary Comp: $669.51kMr. Nicholas M. Johnson (Age 44)Chief Field Operations Officer Comp: $696.4kMr. Jonathan Barrett MacKenzie (Age 52)VP of Finance & Chief Accounting Officer Mr. Steven ZenkerVice President of Investor RelationsMs. Claudia C. Greninger (Age 51)Chief Human Resources Officer More ExecutivesKey CompetitorsForafric GlobalNASDAQ:AFRIChina Xiangtai FoodNASDAQ:PLINMama's CreationsNASDAQ:MAMAThredUpNASDAQ:TDUPLifeway FoodsNASDAQ:LWAYView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 5,975 shares on 5/20/2024Ownership: 0.055%Walleye Trading LLCSold 1,000 shares on 5/17/2024Ownership: 0.000%Jacobs Levy Equity Management Inc.Bought 44,930 shares on 5/16/2024Ownership: 1.594%California State Teachers Retirement SystemSold 591 shares on 5/16/2024Ownership: 0.099%Janus Henderson Group PLCSold 7,205 shares on 5/16/2024Ownership: 0.049%View All Insider TransactionsView All Institutional Transactions MED Stock Analysis - Frequently Asked Questions Should I buy or sell Medifast stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares. View MED analyst ratings or view top-rated stocks. What is Medifast's stock price target for 2024? 2 brokerages have issued 12-month price targets for Medifast's shares. Their MED share price targets range from $25.00 to $82.00. On average, they anticipate the company's stock price to reach $53.50 in the next twelve months. This suggests a possible upside of 119.2% from the stock's current price. View analysts price targets for MED or view top-rated stocks among Wall Street analysts. How have MED shares performed in 2024? Medifast's stock was trading at $67.22 at the beginning of the year. Since then, MED shares have decreased by 63.7% and is now trading at $24.41. View the best growth stocks for 2024 here. When is Medifast's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024. View our MED earnings forecast. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) posted its earnings results on Monday, April, 29th. The specialty retailer reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.78 by $0.12. The specialty retailer earned $174.74 million during the quarter, compared to analyst estimates of $168.90 million. Medifast had a net margin of 7.55% and a trailing twelve-month return on equity of 36.64%. The firm's revenue for the quarter was down 49.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.67 earnings per share. How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast declared a quarterly dividend on Thursday, September 7th. Investors of record on Tuesday, September 19th will be given a dividend of $1.65 per share on Tuesday, November 7th. This represents a $6.60 dividend on an annualized basis and a yield of 27.04%. The ex-dividend date of this dividend is Monday, September 18th. Read our dividend analysis for MED. What ETFs hold Medifast's stock? ETFs with the largest weight of Medifast (NYSE:MED) stock in their portfolio include Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Invesco S&P SmallCap Consumer Staples ETF (PSCC) and Global X Health & Wellness ETF (BFIT). What guidance has Medifast issued on next quarter's earnings? Medifast updated its second quarter 2024 earnings guidance on Monday, April, 29th. The company provided EPS guidance of 0.050-0.400 for the period, compared to the consensus EPS estimate of 0.780. The company issued revenue guidance of $150.0 million-$170.0 million, compared to the consensus revenue estimate of $168.9 million. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM). Who are Medifast's major shareholders? Medifast's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.27%), Jacobs Levy Equity Management Inc. (1.59%), PEAK6 Investments LLC (0.00%), Principal Financial Group Inc. (0.59%), Allspring Global Investments Holdings LLC (0.39%) and Inspire Advisors LLC (0.30%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes and Scott Schlackman. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:MED) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.